MedTrace Logo

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection

NCT04493918 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-08-03

No results posted yet for this study

Summary

This study evaluates the effectiveness of locally implantation of mesenchymal stem cell on vertebral bone defects due to infection of mycobacterium tuberculosis. there are controlled participants who receives placebo and patients who receives implantation of MSc

Conditions

  • Spinal Tuberculosis
  • Mesenchymal Stem Cell

Interventions

COMBINATION_PRODUCT

Mesenchymal Stem cell + Nacl 0.9%

Patient who undergo surgery, debridement, decompression and posterior stabilization injection with Nacl 0.9% 2 ml + MSC 30 million unit

COMBINATION_PRODUCT

NaCl 0.9%

Patient who undergo surgery, debridement, decompression and posterior stabilization injection with Nacl 0.9% 2 ml

Sponsors & Collaborators

  • Ahmad Jabir Rahyussalim

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-21
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04493918 on ClinicalTrials.gov